# Mazumdar-Shaw, who is now Chairperson of Biocon, said it’s part of the five-year phased transition plan for the company.

*biotech · news · 2026-05-06 · The Indian Express*

## Key points

- Biocon is executing a five-year phased leadership transition as part of its succession plan.
- Kiran Mazumdar-Shaw has no children and is succeeded by an external professional rather than family.
- Biocon's R&D pipeline includes over 20 biosimilar assets and GLP-1 peptides.
- Biocon reported Rs 2,242 crore turnover and Rs 609 crore net profit for year ended March 2025.

**Companies:** Biocon, Bicara
**Countries:** India

[Read the full story on The Indian Express](https://indianexpress.com/article/business/claire-mazumdar-lead-biocon-growth-era-10675513/)

---

Canonical: https://newsio.io/n/143dc4d5-2d65-4433-a6d5-4ed6d5f3fbb9/mazumdar-shaw-who-is-now-chairperson-of-biocon-said-its-part-of-the-five-year-ph
Summarized by Newsio from The Indian Express. https://newsio.io/how-it-works